Morton Adam
Mater Health Services, Raymond Tce, South Brisbane, QLD 4101, Australia.
Pregnancy Hypertens. 2015 Oct;5(4):259-62. doi: 10.1016/j.preghy.2015.08.003. Epub 2015 Aug 12.
Primary aldosteronism is the most common cause of secondary hypertension. Less than 50 cases of pregnancy in women with primary aldosteronism have been reported, suggesting the disorder is significantly underdiagnosed in confinement. Accurate diagnosis is complicated by physiological changes in the renin-angiotensin-aldosterone axis in pregnancy, leading to a risk of false negative results on screening tests. The course of primary aldosteronism during pregnancy is highly variable, although overall it is associated with a very high risk of fetal and maternal morbidity and mortality. The optimal management of primary aldosteronism during pregnancy is unclear, with uncertainty regarding the safety of mineralocorticoid antagonists and amiloride, their relative efficacy compared with the antihypertensive medications commonly used during pregnancy, and as to whether prognosis is improved by laparoscopic adrenalectomy where an adrenal adenoma can be demonstrated.
原发性醛固酮增多症是继发性高血压最常见的病因。据报道,患有原发性醛固酮增多症的孕妇不足50例,这表明该疾病在孕期明显诊断不足。孕期肾素 - 血管紧张素 - 醛固酮轴的生理变化使准确诊断变得复杂,导致筛查试验出现假阴性结果的风险。尽管原发性醛固酮增多症在孕期的病程差异很大,但总体而言,它与胎儿和母亲发病及死亡的极高风险相关。孕期原发性醛固酮增多症的最佳管理尚不清楚,关于盐皮质激素拮抗剂和阿米洛利的安全性、它们与孕期常用降压药物相比的相对疗效,以及对于可证实为肾上腺腺瘤的患者进行腹腔镜肾上腺切除术是否能改善预后等问题都存在不确定性。